See more : Riber S.A. (ALRIB.PA) Income Statement Analysis – Financial Results
Complete financial analysis of Cardlytics, Inc. (CDLX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cardlytics, Inc., a leading company in the Advertising Agencies industry within the Communication Services sector.
You may be interested
- Leader Electronics Corporation (6867.T) Income Statement Analysis – Financial Results
- A-Mark Precious Metals, Inc. (AMRK) Income Statement Analysis – Financial Results
- Xi’an Manareco New Materials Co.,Ltd (688550.SS) Income Statement Analysis – Financial Results
- Umbrella Solar Investment, S.A. (USI.MC) Income Statement Analysis – Financial Results
- Tinybeans Group Limited (TNY.AX) Income Statement Analysis – Financial Results
Cardlytics, Inc. (CDLX)
About Cardlytics, Inc.
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 309.20M | 298.54M | 267.12M | 186.89M | 210.43M | 150.68M | 130.37M | 112.82M | 77.63M |
| Cost of Revenue | 178.83M | 185.91M | 163.78M | 123.62M | 130.97M | 96.00M | 80.26M | 72.41M | 52.49M |
| Gross Profit | 130.38M | 112.63M | 103.34M | 63.27M | 79.46M | 54.68M | 50.11M | 40.41M | 25.14M |
| Gross Profit Ratio | 42.17% | 37.73% | 38.69% | 33.86% | 37.76% | 36.29% | 38.44% | 35.82% | 32.38% |
| Research & Development | 51.35M | 54.44M | 38.10M | 17.53M | 11.70M | 16.21M | 12.15M | 13.90M | 11.60M |
| General & Administrative | 58.81M | 81.45M | 66.22M | 46.53M | 36.72M | 34.23M | 20.10M | 21.36M | 18.20M |
| Selling & Marketing | 57.43M | 74.75M | 66.00M | 45.31M | 43.83M | 41.88M | 31.93M | 31.26M | 32.78M |
| SG&A | 116.24M | 156.19M | 132.22M | 91.84M | 80.55M | 76.11M | 52.03M | 52.62M | 50.98M |
| Other Expenses | 98.46M | 37.54M | 29.87M | 7.83M | 4.54M | -2.10M | 6.28M | -13.26M | -432.00K |
| Operating Expenses | 266.05M | 248.17M | 200.19M | 117.20M | 96.78M | 95.60M | 67.21M | 70.74M | 64.78M |
| Cost & Expenses | 444.87M | 434.08M | 363.97M | 240.82M | 227.76M | 191.60M | 147.46M | 143.15M | 117.27M |
| Interest Income | 3.85M | 1.44M | 297.00K | 440.00K | 829.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 6.18M | 2.56M | 12.56M | 3.05M | 1.38M | 3.26M | 8.24M | 0.00 | 0.00 |
| Depreciation & Amortization | 29.52M | 43.74M | 33.66M | 12.42M | 7.40M | 3.28M | 3.03M | 4.22M | 2.19M |
| EBITDA | -99.00M | -418.98M | -89.91M | -39.51M | -12.79M | -45.97M | -8.37M | -24.00M | -37.45M |
| EBITDA Ratio | -32.02% | -30.75% | -22.91% | -22.65% | -6.08% | -20.49% | -10.35% | -0.15% | -49.41% |
| Operating Income | -135.67M | -135.54M | -96.85M | -53.92M | -17.33M | -40.92M | -17.10M | -56.23M | -39.64M |
| Operating Income Ratio | -43.88% | -45.40% | -36.26% | -28.85% | -8.23% | -27.15% | -13.12% | -49.84% | -51.06% |
| Total Other Income/Expenses | 968.00K | -8.93M | -13.83M | -1.50M | 181.00K | -12.13M | -2.54M | -19.46M | -1.00M |
| Income Before Tax | -134.70M | -466.71M | -136.43M | -55.42M | -17.14M | -53.04M | -19.64M | -75.70M | -40.64M |
| Income Before Tax Ratio | -43.56% | -156.33% | -51.07% | -29.65% | -8.15% | -35.20% | -15.07% | -67.09% | -52.35% |
| Income Tax Expense | 0.00 | -1.45M | -7.86M | 3.05M | 548.00K | -12.13M | 5.74M | 32.11M | -16.00K |
| Net Income | -134.70M | -465.26M | -128.57M | -58.47M | -17.69M | -53.04M | -19.64M | -75.70M | -40.63M |
| Net Income Ratio | -43.56% | -155.85% | -48.13% | -31.29% | -8.41% | -35.20% | -15.07% | -67.09% | -52.33% |
| EPS | -3.69 | -13.92 | -3.99 | -2.15 | -0.75 | -2.78 | -1.01 | -5.40 | -2.90 |
| EPS Diluted | -3.69 | -13.92 | -3.99 | -2.15 | -0.75 | -2.78 | -1.01 | -5.40 | -2.90 |
| Weighted Avg Shares Out | 36.49M | 33.42M | 32.20M | 27.21M | 23.75M | 19.06M | 19.52M | 14.03M | 14.03M |
| Weighted Avg Shares Out (Dil) | 36.49M | 33.42M | 32.20M | 27.21M | 23.75M | 19.06M | 19.52M | 14.03M | 14.03M |
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Cardlytics, Inc. (CDLX)
NEW YORK, NY / ACCESSWIRE / August 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial...
CDLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Cardlytics, Inc. and Encourages Investors to Contact the Firm Today!
NEW YORK, NY / ACCESSWIRE / August 23, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX). Investors who purchased Cardlytics securities are encouraged to obtain...
An Investigation Has Commenced on Behalf of Cardlytics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your CDLX Losses.
NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial...
CDLX Investors Have Opportunity to Join Cardlytics, Inc. Securities Fraud Investigation with the Schall Law Firm
LOS ANGELES , Aug. 22, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ: CDLX) for violations of the securities...
Cardlytics, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - CDLX
NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial...
The Schall Law Firm Urges Cardlytics Inc. Investors To Join A Securities Fraud Investigation
LOS ANGELES, CA / ACCESSWIRE / August 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Cardlytics, Inc. (CDLX)
NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial...
CDLX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Cardlytics, Inc. and Encourages Stockholders to Contact the Firm!
NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX). Investors who purchased Cardlytics securities are encouraged to obtain...
Cardlytics, Inc. (CDLX) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
NEW YORK, NY / ACCESSWIRE / August 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial...
Source: https://incomestatements.info
Category: Stock Reports